Literature DB >> 6807228

Prevalence of Trypanosoma cruzi-like infection of Colombian bats.

C J Marinkelle.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6807228     DOI： 10.1080/00034983.1982.11687517

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  5 in total

Review 1.  "Visiting old, learn new": taxonomical overview of chiropteran trypanosomes from the morphology to the genes.

Authors:  Hiroshi Sato; Eliakunda Mafie
Journal:  Parasitol Res       Date:  2022-02-02       Impact factor: 2.289

2.  Phylogenetic analysis of Bolivian bat trypanosomes of the subgenus schizotrypanum based on cytochrome B sequence and minicircle analyses.

Authors:  Lineth García; Sylvia Ortiz; Gonzalo Osorio; Mary Cruz Torrico; Faustino Torrico; Aldo Solari
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

3.  Natural infection with Trypanosoma cruzi in bats captured in Campeche and Yucatán, México.

Authors:  Marco Torres-Castro; Naomi Cuevas-Koh; Silvia Hernández-Betancourt; Henry Noh-Pech; Erendira Estrella; Belén Herrera-Flores; Jesús A Panti-May; Etienne Waleckx; Javier Sosa-Escalante; Ronald Peláez-Sánchez
Journal:  Biomedica       Date:  2021-05-31       Impact factor: 0.935

4.  Ecological connectivity of Trypanosoma cruzi reservoirs and Triatoma pallidipennis hosts in an anthropogenic landscape with endemic Chagas disease.

Authors:  Janine M Ramsey; Ana E Gutiérrez-Cabrera; Liliana Salgado-Ramírez; A Townsend Peterson; Victor Sánchez-Cordero; Carlos N Ibarra-Cerdeña
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

5.  Comparative genomic analysis of human infective Trypanosoma cruzi lineages with the bat-restricted subspecies T. cruzi marinkellei.

Authors:  Oscar Franzén; Carlos Talavera-López; Stephen Ochaya; Claire E Butler; Louisa A Messenger; Michael D Lewis; Martin S Llewellyn; Cornelis J Marinkelle; Kevin M Tyler; Michael A Miles; Björn Andersson
Journal:  BMC Genomics       Date:  2012-10-05       Impact factor: 3.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.